Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma: do we still need biopsies?

Abstract Objective Early diagnosis of gastric cancer may be achieved through surveillance of patients with extensive gastric intestinal metaplasia (eGIM). However, diagnosis of eGIM generally implies histology. We aimed at determining the accuracy of high-resolution endoscopy with light-narrow band imaging (NBI) to assess the presence of eGIM on a per-patient basis. Material and methods Prospective cohort of 60 patients divided into two groups: derivation cohort (n = 25) to evaluate the reliability and validity, and a real-time validation group (n = 35). In the derivation group, six endoscopists with two levels of expertise were asked to estimate the grade of GIM based in endoscopic images (white light endoscopy, light-NBI and amplification/near focus). In the real-time validation set, experienced endoscopists were asked to similarly record their real-time optical diagnosis. Histology was then considered as the gold standard. Results In the derivation group diagnosis accuracy was 60% with WLE (non-expert 59% vs. 61% experts), increasing to 73% after NBI magnification (non-expert 63% vs. 83% expert, p < 0.05). Moreover, proportion of agreement with histology was 83%, with a correct diagnosis of eGIM in 87% for experienced observers. In the real-time group experts obtained 89% global diagnostic accuracy correctly identifying 91% of the eGIM. The sensitivity, specificity, LR + and LR- of real-time endoscopic diagnosis of eGIM was 0.92 (CI95%:0.67–0.99), 0.96 (0.79–0.99), 21.1 (3.08–144) and 0.09 (0.013–0.57). Conclusion For the first time the reliability of high-resolution endoscopy with light-NBI for extension of GIM is described. Our results suggest that more than 90% of individuals at risk could be identified without the need for biopsies, simplifying the current recommendations.

[1]  E. Kuipers,et al.  Identification of gastric atrophic changes: from histopathology to endoscopy , 2015, Endoscopy.

[2]  Nayoung Kim,et al.  Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer , 2015, Journal of cancer prevention.

[3]  M. Dinis-Ribeiro,et al.  Cost‐Utility Analysis of Endoscopic Surveillance of Patients with Gastric Premalignant Conditions , 2014, Helicobacter.

[4]  P. Pimentel-Nunes,et al.  The learning curve for narrow-band imaging in the diagnosis of precancerous gastric lesions by using Web-based video. , 2014, Gastrointestinal endoscopy.

[5]  W. Dong,et al.  Meta-Analysis: Narrow Band Imaging for Diagnosis of Gastric Intestinal Metaplasia , 2014, PloS one.

[6]  M. Dinis-Ribeiro,et al.  Prevalence of gastric precancerous conditions: a systematic review and meta-analysis , 2014, European journal of gastroenterology & hepatology.

[7]  M. Leja,et al.  Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies , 2013, Scandinavian journal of gastroenterology.

[8]  D. Lam-Himlin Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2013 .

[9]  P. Sharma,et al.  A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions , 2012, Endoscopy.

[10]  E. Kuipers,et al.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.

[11]  E. Kuipers,et al.  Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.

[12]  A. Sigurdsson,et al.  The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.

[13]  S. Tannenbaum,et al.  A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1975, The Lancet.